J 2014

Czech multicenter research database of severe COPD

NOVOTNA, Barbora; V. KOBLIZEK; J. ZATLOUKAL; Marek PLUTINSKÝ; Karel HEJDUK et al.

Základní údaje

Originální název

Czech multicenter research database of severe COPD

Autoři

NOVOTNA, Barbora; V. KOBLIZEK; J. ZATLOUKAL; Marek PLUTINSKÝ; Karel HEJDUK; Zuzana ZBOŽÍNKOVÁ; Jiří JARKOVSKÝ ORCID; O. SOBOTIK; T. DVORAK a P. SAFRANEK

Vydání

International Journal of chronic obstructive pulmonary disease, Albany, Dove Medical Press Ltd. 2014, 1178-2005

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30203 Respiratory systems

Stát vydavatele

Nový Zéland

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 3.141

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14110/14:00078311

Organizační jednotka

Lékařská fakulta

EID Scopus

Klíčová slova anglicky

phenotypes; comorbidities; exacerbations; all-cause mortality; prospective study

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 24. 4. 2015 14:01, Ing. Mgr. Věra Pospíšilíková

Anotace

V originále

Purpose: Chronic obstructive pulmonary disease (COPD) has been recognized as a heterogeneous, multiple organ system-affecting disorder. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) places emphasis on symptom and exacerbation management. The aim of this study is examine the course of COPD and its impact on morbidity and all-cause mortality of patients, with respect to individual phenotypes and GOLD categories. This study will also evaluate COPD real-life patient care in the Czech Republic. Patients and methods: The Czech Multicentre Research Database of COPD is projected to last for 5 years, with the aim of enrolling 1,000 patients. This is a multicenter, observational, and prospective study of patients with severe COPD (post-bronchodilator forced expiratory volume in 1 second <= 60%). Every consecutive patient, who fulfils the inclusion criteria, is asked to participate in the study. Patient recruitment is done on the basis of signed informed consent. The study was approved by the Multicentre Ethical Committee in Brno, Czech Republic. Results: The objective of this paper was to outline the methodology of this study. Conclusion: The establishment of the database is a useful step in improving care for COPD subjects. Additionally, it will serve as a source of data elucidating the natural course of COPD, comorbidities, and overall impact on the patients. Moreover, it will provide information on the diverse course of the COPD syndrome in the Czech Republic.

Návaznosti

15/14/NAP, interní kód MU
Název: Sledování výskytu deficitu alfa 1 antitrypsinu u pacientů s těžkou formou CHOPN
Investor: Ministerstvo zdravotnictví ČR, Sledování výskytu deficitu alfa 1 antitrypsinu u pacientů s těžkou formou CHOPN